Article Contents ::
- 1 The Brand Name INFLUVAC Has Generic Salt :: INFLUENZA
- 2 INFLUVAC Is From Company Cipla Priced :: Rs. 650
- 3 INFLUVAC have INFLUENZA is comes under Sub class #N/A of Main Class #N/A
- 4 Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name INFLUVAC Has Generic Salt :: INFLUENZA
INFLUVAC Is From Company Cipla Priced :: Rs. 650
INFLUVAC have INFLUENZA is comes under Sub class #N/A of Main Class #N/A
Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
|Salt Name : OR Generic Name||Form||Price : MRP /Probable||Packing|
Indications for Drugs ::
Prevention of influenza caused by Influenza Virus types A and B in adults and children aged 6 months and over.
Drug Dose ::
Adults and Children >36 months: One 0.5-mL dose. Children 6-35 months: One 0.25-mL dose. For children (<8 years) who have not previously been vaccinated, a 2nd dose should be given after an interval of at least 4 weeks. Administration: IM route or deep SC injection. Contraindication ::
Known anaphylactic hypersensitivity reactions to egg proteins (eggs or egg products), chicken proteins, or any other component of the vaccine including traces (formaldehyde, octoxino l 9 (Triton X-100) and neomycin). Immunisation should not be performed during a febrile or acute illness.
Drug Precautions ::
Since this vaccine contains traces of formaldehyde, octoxinol 9 (Triton X-100) and neomycin due to the use of these substances during production, it should be used with caution in subjects with a hypersensitivity to any of these substances. Patients with a history of Guillain-Barré Syndrome (GBS) with an onset related in time to influenza vaccination may be at increased risk of again developing GBS if given influenza vaccine. Use in pregnancy & lactation: Safety of use during pregnancy has not been established; benefits of vaccination should be weighed against potential risks. However, as an inactivated vaccine, it does not share the theoretical risks associated with live vaccines. It is not known if this is excreted in human milk; hence, caution should used when administering vaccine to breastfeed ing women. However, as an inactivated vaccine, it does not share the theoretical risks associated with live vaccines.
Drug Side Effects ::
In children under 5 years of age, systemic reactions (e.g. fever, malaise, myalgia) may be more pronounced. Local Reactions: Erythema (redness), swelling, pain, ecchymosis, induration. Systemic Reactions: Fever, malaise, shivering, fatigue, headache, sweating, joint and muscular pain. These reactions usually disappear within 1-2 days without treatment. Rarely: Neuralgia, paresthesia, convulsions and transient thrombocytopenia Allergic reactions leading to shock in rare cases. Vasculitis with transient renal involvement, in very rare cases.
Pregnancy category ::
Drug Mode of Action ::
Influenza virus vaccine inactivated promotes immunity to influenza virus by inducing specific antibody formation.
Drug Interactions ::
Reduced immunological response w/ immunosuppressants.